KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Change in Account Payables (2016 - 2025)

Pacific Biosciences Of California has reported Change in Account Payables over the past 16 years, most recently at $1.7 million for Q4 2025.

  • Quarterly results put Change in Account Payables at $1.7 million for Q4 2025, down 52.55% from a year ago — trailing twelve months through Dec 2025 was $2.5 million (up 76.65% YoY), and the annual figure for FY2025 was $2.5 million, up 76.65%.
  • Change in Account Payables for Q4 2025 was $1.7 million at Pacific Biosciences Of California, up from $1.3 million in the prior quarter.
  • Over the last five years, Change in Account Payables for PACB hit a ceiling of $6.6 million in Q1 2024 and a floor of -$5.6 million in Q3 2024.
  • Median Change in Account Payables over the past 5 years was $180000.0 (2022), compared with a mean of $667789.5.
  • Biggest five-year swings in Change in Account Payables: surged 4065.36% in 2022 and later tumbled 1520.0% in 2023.
  • Pacific Biosciences Of California's Change in Account Payables stood at $6.2 million in 2021, then tumbled by 107.88% to -$486000.0 in 2022, then tumbled by 208.64% to -$1.5 million in 2023, then surged by 341.8% to $3.6 million in 2024, then plummeted by 52.55% to $1.7 million in 2025.
  • The last three reported values for Change in Account Payables were $1.7 million (Q4 2025), $1.3 million (Q3 2025), and $1.0 million (Q2 2025) per Business Quant data.